Erbitux and Ellence drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Erbitux (cetuximab) and Ellence (epirubicin hydrochloride). Common drug interactions include neutrophil count decreased among females and blood potassium decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Erbitux and Ellence. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Erbitux?

Erbitux has active ingredients of cetuximab. It is often used in cancer. eHealthMe is studying from 19,276 Erbitux users. Check the latest studies of Erbitux.

What is Ellence?

Ellence has active ingredients of epirubicin hydrochloride. eHealthMe is studying from 943 Ellence users. Check the latest studies of Ellence.

On Jul, 07, 2026

12 people who take Erbitux and Ellence together, and have interactions are studied.

What are the common drug interactions of Erbitux and Ellence, by gender? *:

female:

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Febrile neutropenia (fever with reduced white blood cells)
Hyperkalaemia (damage to or disease of the kidney)
Infusion related reaction

male:

Blood potassium decreased
Blood pressure immeasurable
Febrile neutropenia (fever with reduced white blood cells)
Malignant neoplasm progression (cancer tumour came back)
Neuropathy peripheral (surface nerve damage)
Neutropenia (an abnormally low number of neutrophils)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Oesophageal adenocarcinoma metastatic (a cancer tumour of an epithelium in oesophagus spreads to other parts)
Pulmonary embolism (blockage of the main artery of the lung)
Rash

What are the common drug interactions of Erbitux and Ellence, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)
Malignant neoplasm progression (cancer tumour came back)
Neuropathy peripheral (surface nerve damage)
Oesophageal adenocarcinoma metastatic (a cancer tumour of an epithelium in oesophagus spreads to other parts)
Rash
Respiratory failure (inadequate gas exchange by the respiratory system)

40-49:

n/a

50-59:

Pulmonary embolism (blockage of the main artery of the lung)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Unresponsive to stimuli
Blood pressure immeasurable
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Infusion related reaction
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

60+:

Blood potassium decreased
Caecitis (inflammation of the cecum)
Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Dehydration (dryness resulting from the removal of water)
Neutropenia (an abnormally low number of neutrophils)
Renal failure (kidney dysfunction)

* Approximation only. Some reports may have incomplete information.

Do you take Erbitux and Ellence?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously